Cargando…
SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits
In recent years, following the publication of results from several RCTs, first on cardiovascular and more recently on renal outcomes, SGLT2is have become the standard of care to prevent diabetic kidney disease and slow its progression. This narrative review focuses on biological mechanisms, both ren...
Autores principales: | Leoncini, Giovanna, Russo, Elisa, Bussalino, Elisabetta, Barnini, Cecilia, Viazzi, Francesca, Pontremoli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122991/ https://www.ncbi.nlm.nih.gov/pubmed/33922865 http://dx.doi.org/10.3390/ijms22094441 |
Ejemplares similares
-
Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
por: Russo, Elisa, et al.
Publicado: (2023) -
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system
por: Viazzi, Francesca, et al.
Publicado: (2013) -
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022) -
Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient
por: Viazzi, Francesca, et al.
Publicado: (2014) -
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney
por: Viazzi, Francesca, et al.
Publicado: (2013)